Trials / Completed
CompletedNCT01168830
First in Man Trial - BIOSOLVE-I
BIOTRONIKS-Safety and Clinical Performance Of the First Drug-Eluting Generation Absorbable Metal Stent In Patients With de Novo Lesions in NatiVE Coronary Arteries (BIOSOLVE - I)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Biotronik AG · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
First in Man Trial with the drug eluting absorbable metal scaffold. To assess safety
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AMS-3.0 |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2011-12-01
- Completion
- 2014-12-01
- First posted
- 2010-07-23
- Last updated
- 2015-02-05
Locations
6 sites across 4 countries: Belgium, Germany, Netherlands, Switzerland
Source: ClinicalTrials.gov record NCT01168830. Inclusion in this directory is not an endorsement.